Bone Resorption, Osteoclastogenesis and Adalimumab
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Acronyms BROCAII
- 07 May 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 07 May 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 27 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.